Stable silk protein fragment compositions
A composition is disclosed that includes pure silk fibroin-based protein fragments that are substantially devoid of sericin, wherein the composition has an average weight average molecular weight ranging from about 17 kDa to about 38 kDa, wherein the composition has a polydispersity of between about 1.5 and about 3.0, wherein the composition is substantially homogeneous, wherein the composition between 0 ppm to about 500 ppm of inorganic residuals, and wherein the composition includes between 0 ppm to about 500 ppm of organic residuals.
1. A substantially solid composition comprising silk fibroin protein fragments that are substantially devoid of sericin, the silk fibroin protein fragments having an average weight average molecular weight selected from about 17 kDa to about 38 kDa, about 35 kDa to about 40 kDa, about 40 kDa to about 45 kDa, about 45 kDa to about 50 kDa, about 50 kDa to about 55 kDa, or about 39 kDa to about 80 kDa, and a polydispersity of about 1.5 to about 3.0, wherein the silk fibroin protein fragments, when in a solution:
form a substantially homogeneous solution comprising between 0 ppm to about 500 ppm of inorganic residuals and between 0 ppm to about 500 ppm of organic residuals, and do not spontaneously or gradually gelate and do not visibly change in color or turbidity for at least 10 days.
2. The composition of claim 1 , wherein the silk fibroin protein fragments comprise about 1.0% to about 50.0% crystalline protein domains.
3. The composition of claim 1 , wherein the silk fibroin protein fragments comprise about 1.0% to about 10.0%, about 10.0% to about 20.0%, about 20.0% to about 30.0%, about 30.0% to about 40.0%, or about 40.0% to about 50.0% crystalline protein domains.
4. The composition of claim 1 , wherein the silk fibroin protein fragments comprise a crystalline portion of about two-thirds and an amorphous region of about one-third or a crystalline portion of about one-half and an amorphous region of about one-half.
5. The composition of claim 1 , wherein a ratio of crystalline portion to amorphous region in the silk fibroin protein fragments ranges from about 99% crystalline portion to 1% amorphous region, to about 1% crystalline portion to 99% amorphous region.
6. The composition of claim 1 , wherein the silk fibroin protein fragments comprise a 99% crystalline portion and a 1% amorphous region, a 95% crystalline portion and a 5% amorphous region, a 90% crystalline portion and a 10% amorphous region, an 85% crystalline portion and a 15% amorphous region, an 80% crystalline portion and a 20% amorphous region, a 75% crystalline portion and a 25% amorphous region, a 70% crystalline portion and a 30% amorphous region, a 65% crystalline portion and a 35% amorphous region, a 60% crystalline portion and a 40% amorphous region, a 50% crystalline portion and a 50% amorphous region, a 40% crystalline portion and a 60% amorphous region, a 35% crystalline portion and a 65% amorphous region, a 30% crystalline portion and a 70% amorphous region, a 25% crystalline portion and a 75% amorphous region, a 20% crystalline portion and a 80% amorphous region, a 15% crystalline portion and a 85% amorphous region, a 10% crystalline portion and a 90% amorphous region, a 5% crystalline portion and a 90% amorphous region, or a 1% crystalline portion and a 99% amorphous region.
7. The composition of claim 1 , wherein the composition is soluble in a liquid at room temperature.
8. The composition of claim 1 , wherein the concentration of the silk fibroin protein fragments in the composition is about 30.0 wt. % to about 99.5 wt. %.
9. The composition of claim 1 , wherein the concentration of the silk fibroin protein fragments in the composition is about 30.0 wt. % to about 40.0 wt. %, about 40.0 wt. % to about 50.0 wt. %, about 50.0 wt. % to about 60.0 wt. %, about 60.0 wt. % to about 70.0 wt. %, about 70.0 wt. % to about 80.0 wt. %, about 80.0 wt. % to about 90.0 wt. %, or about 90.0 wt. % to about 99.5 wt. %.
10. The composition of claim 1 , wherein the concentration of the silk fibroin protein fragments in the composition is about 0.1 wt. % to about 30.0 wt. %.
11. The composition of claim 1 , wherein the concentration of the silk fibroin protein fragments in the composition is about 0.1 wt. % to about 10.0 wt. %, about 10.0 wt. % to about 20.0 wt. %, or about 20.0 wt. % to about 30.0 wt. %.
12. The composition of claim 1 , wherein the composition is annealed.
13. The composition of claim 1 , further comprising one or more therapeutic agents.
14. The composition of claim 1 , wherein the silk fibroin protein fragments are hypoallergenic.
15. The composition of claim 1 , wherein the silk fibroin protein fragments, when in a solution, do not spontaneously or gradually gelate and do not visibly change in color or turbidity for at least 30 days.